Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Preterm Kids' brains tracked to age 9 in new study

NCT ID NCT05990582

Knowledge-focused Sponsor: Noordwest Ziekenhuisgroep Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 02, 2026 · Updated 2 times

Summary

This study follows children born moderately or late preterm (32-36 weeks) to age 9, measuring their thinking, movement, language, behavior, and growth. Researchers compare these kids to full-term peers to understand long-term effects. The goal is to learn how early development predicts later outcomes, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

153 people

The number who actually took part.

Started

Aug 2023

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

9 to 9 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

In order to be eligible to participate in this study, a subject must meet all the following criteria: * The participant is born in or transferred to the NWZ Alkmaar between January 1st, 2014 and April 18th, 2016 (the time in which the participants of trial NL50800.094.14 were born). * The participant born at a gestational age from 32 to 35+6 weeks. * Both parents of the participant have given informed consent to participate in the 9 years trial In order to be eligible to participate in the control group of this study, a subject must meet all the following criteria: * The participant is 9 years old when participating in this study and is a friend or classmate of the included MLPTI or has visited a GGD site for the 9 years vaccination and is willing to participate or is a (grand)child of an employee of Noordwest Hospital and is living in the area of Alkmaar (\< 20 km). * Both parents of the participant have given informed consent for the participation of the study. A potential subject who meets any of the following criteria will be excluded from participation in this study: * The participant's parents are not able to fill out questionnaires or perform tests in Dutch. * The participant has a severe developmental or genetic disorder and is thereby not able to perform the tests. * The participant is not able to come to the outpatient clinic to do the tests. A potential subject who meets any of the following criteria will be excluded from participation in this study as part of the control group: * The participant is born with a GA \< 37 weeks. * The participant has a severe developmental or genetic disorder and is thereby not able to perform the tests. * The participant had complications after birth (e.g. admission at a Neonatal ward) * The participant needs special education

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Developmental delay are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

follicular lymphoma learning disability Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Developmental delay Growth delay Preterm birth

Contacts and locations

Locations

  • Noordwest Ziekenhuisgroep

    Alkmaar, 1815JD, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.